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2618Objective: To identify the outcomes of surgically treated subaortic stenosis in a national population.
Methods: From 2000 to 2013, 1047 patients aged<40 years underwent 1142 subaortic stenosis procedures. Of the
1047 patients, 484 (46.2%) were considered to have complex stenosis (CS) because at or before the first operation
they had mitral valve (MV) disease, aortic valve disease, aortic coarctation or an interrupted aortic arch.
Results: The 30-day mortality was 0.7% for simple stenosis (SS), 2.3% for CS (P ¼ .06), and 1.6% overall.
Age< 1 year (P< .01), MV procedure (P ¼ .02) and an interrupted aortic arch at the index procedure
(P<.01) were risk factors for early death. Konno-type procedure early mortality was 2.4%. The 12-year survival
was 97.1%, with a significant difference between SS and CS (hazard ratio [HR], 4.53; P ¼ .02). Having MV
disease alone (HR, 4.11; P ¼ .02), MV disease plus aortic coarctation (HR, 6.73; P ¼ .008), and age< 1
year (HR, 6.72; P<.001) were risk factors for late mortality. Freedom from subaortic reintervention overall
was 92.3% and 88.5% at 5 and 12 years, respectively, much greater with CS than with SS (HR, 4.91;
P< .0001). The independent risk factors for reintervention were younger age at the index procedure (HR,
0.1/y; P ¼ .002), concomitant MV procedure (HR, 2.68; P ¼ .019), ventricular septal defect plus interrupted
aortic arch (HR, 3.19; P ¼ .014), and ventricular septal defect plus aortic coarctation (HR, 2.41; P ¼ .023).
Undergoing a concomitant aortic valve procedure at the index procedure was protective (HR, 0.29; P ¼ .025).
Conclusions: Patients with SS had excellent outcomes. However, those with CS had worse long-term survival
and freedom from reintervention, with morbidity and mortality greatest in young patients with multiple lesions.
Additional evaluation in large-scale prospective studies is warranted. (J Thorac Cardiovasc Surg
2014;148:2618-26)Subaortic stenosis (SAS) is a polymorphic condition.
Anatomically, it can range from an isolated discrete stenosis
to complex forms of left ventricular (LV) outflow tract
obstruction. Other anatomic associations have been well
described, including septal malalignment and multilevel
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The Journal of Thoracic and Cardiovascular Sursome adjacent lesions, such as aortic valve (AV) disease,
evolve after primary treatment of SAS. Surgical treatment
is generally successful; however, a risk of recurrence exists,
which has been reported at 7.2% to 27%.1-6 Many factors
influence the long-term outcomes, including patient age
and size, preoperative gradient, surgery timing, performance
of myectomy, and anatomic complexity. Single-institution
studies have been restricted by patient numbers, and multi-
center studies are better placed to offer more insight.
In the United Kingdom, the Central Cardiac Audit Data-
base (CCAD), hosted by the National Institute for Cardio-
vascular Outcomes Research, has collected data from
congenital UK centers from 2000 onward. It captures all pe-
diatric cardiac surgical and catheter procedures and all adult
congenital cardiac procedures (defined as those performed
for a cardiac defect present from birth). The audit database
has limited clinical information; nevertheless, through com-
plete procedure coverage and linkage with survival statis-
tics, it has provided a unique opportunity to examine the
outcomes of all patients undergoing certain procedures.
The objectives of the present SAS study were to (1)
describe the early- and long-term survival and freedom
from reintervention in a national population of consecutive,gery c December 2014
Abbreviations and Acronyms
AV ¼ aortic valve
AVR ¼ AV replacement
CCAD ¼ Central Cardiac Audit Database
CI ¼ confidence interval
CoA ¼ aortic coarctation
CS ¼ complex stenosis
HR ¼ hazard ratio
IAA ¼ interrupted aortic arch
LV ¼ left ventricular
MV ¼ mitral valve
SAS ¼ subaortic stenosis
SS ¼ simple stenosis
VSD ¼ ventricular septal defect
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Dunselected cases; (2) examine how the outcomes of simple
stenosis (SS) and complex stenosis (CS), further defined in
subsequent section, differ; and (3) describe the influence of
AV procedures such as AV replacement (AVR), Ross, and
Konno. The results are presented in aggregate for the cohort
and for the various subgroups.METHODS
Data Set
The National Institute for Cardiovascular Outcomes Research brings
together analysts and clinicians with the aim of providing data about surgi-
cal and catheter-based heart procedures and outcomes. The results are ob-
tained by collecting key validated data from all UK heart units into
cardiovascular registries (available at: https://nicor4.nicor.org.uk/). The
National Institute for Cardiovascular Outcomes Research mechanism for
congenital data capture, cleaning, and validation is similar to that adopted
for adult cardiac surgery.7 Using linkage with census records at the Office
of National Statistics, the audit reports survival at 30 days and 1 year after
the index procedure. Distilled information from the core database is re-
ported online. The data represent a ‘‘real world’’ picture. CCAD data are
actively audited, both internally and externally. About 15% of the patients
will have no follow-up data beyond their hospital stay, because linkagewith
survival registries of Northern Ireland and Scotland cannot be done consis-
tently with a National Health Services number, 5%will be foreign patients,
and the remainder will have social data errors.
The indications for the primary subaortic (index) procedure and subse-
quent reinterventions were provided by multidisciplinary groups at each
center. The submitted procedure codes are those recorded in each center’s
logs and are audited regularly. The additional diagnoses were those
selected by the reporting clinicians; the concordance between the proce-
dure performed and the diagnosis reported was also audited, with the over-
all key data quality index>95%.
Recruitment into the study continued until April 2012, when the last set
of validated data was available. The data were anonymized, and the need
for patient-level consent was waived by the CCAD research board. The
procedures performed for degenerative causes associated with hereditary
conditions (eg, Marfan syndrome) were not considered congenital. Coex-
isting complex heart abnormalities were excluded (ie, univentricular con-
ditions, valvular atresia, atrioventricular septal defect, transposition of
the great arteries, common arterial trunk, Fallot and Fallot-type defects, se-
vere vascular abnormalities [eg, major aortopulmonary collaterals], or
isomerism). Patients with aortic coarctation (CoA) and interrupted aorticThe Journal of Thoracic and Cararch (IAA) were included owing to the clinical significance in the context
of multilevel left-sided obstruction. The patients were considered to have
SS or CS according to the definitions listed in Table 1. Of the 1047 patients,
58 had MVor AVabnormalities noted during follow-up (but not before the
index procedure) that led to uncertainty regarding the initial diagnosis of
the pathologic entity. We believe that, in principle, they satisfied the condi-
tions of CS; however, having incomplete diagnosis and clinical history
data, we preferred that such patients remain unassigned to either group
(but their data were still included in the aggregate analysis because of valid
survival data). All tests involving comparisons between CS and SS were
performed initially including these patients in the CS group and then
excluding them, with insignificant differences in the results. Thus, the re-
ported results are from the analyses without such patients. Because of
the usage of 2 ambiguous procedure codes (ie, 120822 [subaortic obstruc-
tion relief] and 120713 [LV outflow tract obstruction relief]), it was not
possible to determine the proportion of patients with myectomy.
Statistical Analysis
The frequencies are given as the absolute numbers and percentages,
continuous values as the mean  standard deviation, or median and inter-
quartile range. Short-termmortality was calculated per procedure, reported
according to the discharge status and 30-day life status (where available).
The estimates of long-term survival were made using the Kaplan-Meier
method, with all-causemortality as the failure event. Freedom from reinter-
vention was estimated using the Kaplan-Meier method and a competing
risks method (‘‘stcompet’’ routine for STATA; StataCorp, College Station,
Tex) using reintervention and death as competing events. The predictor var-
iables for short-term mortality were determined using the Fisher exact test
or logistical regression analysis. For long-term survival and freedom from
reintervention, we performed univariable analysis using the variables listed
below. To identify independent risk factors, we used a multivariable Cox
proportional hazards regression model and a competing risks regression
model8 (1 variable/10 events) with stepwise forward selection and back-
ward elimination (with significant variables from univariable analysis,
P<.1). Age (continuous) and categorical (<1 and>1 year), sex, concom-
itant procedures (mitral valve [MV] or AV procedures, ventricular septal
defect [VSD] closure, CoA repair), other abnormalities present at the index
surgery (MV, AV, CoA, VSD, or associations such as VSDþCoA,
MVþCoA, and VSDþIAA), Konno-type procedure, and genetic disorders
were examined. The results from the Cox and competing risks regression
analyses were similar; thus, we chose to report only the hazard ratio
(HR) and not the sub-HRs for practical reasons. Complex versus simple
SAS comparisons were performed separately, independent of the multivari-
able model. Stratification by center was used, as appropriate. Adjusted HRs
are given when bivariable or multivariable models were used. The propor-
tional hazard assumption was tested visually and also using Schoenfeld
residuals. The population characteristics were compared using the Mann-
Whitney U test, t test, and chi-square test. Statistical analyses were
performed using STATA/IC, version11.2 (StataCorp LP).RESULTS
A total of 1673 patients with a SAS relief procedure per-
formed from April 1, 2000 to March 31, 2012 were
analyzed initially. Those with complex heart abnormalities
(n¼ 456), age>40 years (n¼ 77), hypertrophic cardiomy-
opathy (n ¼ 37), transcatheter approach (n ¼ 15), unknown
age at the index procedure (n¼ 41) were eliminated, result-
ing in a final group of 1047 patients. The completeness of
the data is presented in Table 2.
These 1047 patients underwent 1142 subaortic relief
procedures, with 82 a Konno-type operation (includingdiovascular Surgery c Volume 148, Number 6 2619
TABLE 1. Definitions of terms
SAS reintervention Any reoperation or catheter-based procedure related to relief of subaortic valve region obstruction
AV reintervention Reoperation or catheter-based procedure related to AVapparatus (including valvuloplasty/valvotomy andAVR of any type
with or without root replacement)
Complex SAS SASwith1 of the following associated diagnoses: AVorMV pathology, CoA, IAA, or tunnel stenosis requiring a Konno
operation
Simple SAS SAS associated with, at most, isolated VSD, pulmonary or tricuspid valve abnormalities, or other miscellaneous minor
defects
Associated AV pathology The existence of an AV abnormality, stenosis, or regurgitation before the index operation (not including bicuspid valve
with no hemodynamic effect)
Associated MV pathology The existence of a MV abnormality, stenosis, or regurgitation at or before the index operation
Associated VSD, CoA, IAA Documented VSD, CoA, or IAA at any point during patient follow-up, corrected or not
Genetic syndrome Documented genetic disease at any point (Marfan, Noonan, DiGeorge, Down, Turner, Edwards, andWilliams syndromes
or nonclassified chromosomal abnormalities)
Index operation First SAS relief procedure captured in database
SAS, Subaortic stenosis; AV, aortic valve; AVR, aortic valve replacement; MV, mitral valve; CoA, coarctation or hypoplasia of the aorta; IAA, interrupted aortic arch; VSD, ven-
tricular septal defect.
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tient characteristics are listed in Table 3, and the neonatal
group is described in detail in Table 4. The CS group had
longer bypass, crossclamp, and circulatory arrest times
and a longer hospital stay than did the SS group
(P<.0001) and were younger, smaller, and had a shorter
follow-up period (P<.01). Data related to the associated
abnormalities and concomitant procedures for the CS group
(n ¼ 484) are listed in Table 5. Of the 505 patients with SS,
21 (4.2%) had a genetic disorder, 116 (23.0%) a VSD, and
97 (19.2%) VSD repair. A total of 140 patients (13.4%) had
had myectomy reported; however, because of the ambig-
uous coding, we believed the number was an underestimate.
Thus, we did not examine the influence of myectomy.
Early Mortality
Hospital mortality was 1.24% overall (0.6% for SS,
1.9% for CS). The short-term mortality (at 30 days) was
1.6% overall, 0.7% for SS, and 2.3% for CS (P ¼ .057).
On bivariable analysis, the risk factors for short-term mor-
tality were a MV procedure at the index operation (5.63%
vs 1.30%; P ¼ .02), age < 1 year (9.4% vs 0.8%;TABLE 2. Data completeness
Variable Data complete (%)
NHS number ID 83.57
Diagnosis 96.75
Patient weight 95.03
Sternotomy number 73.73
Bypass time 76.22
Crossclamp time 76.41
Arrest time 93.31
Hospitalization period 97.90
Discharge status 99.90
30-d life status 85.96
Follow-up life status 85.67
NHS, National Health System.
2620 The Journal of Thoracic and Cardiovascular SurP< .001) and an IAA at the index procedure (7.8% vs
1.3%; P ¼ .007). A total of 40 patients in the CS group
had an IAA, with two thirds of the early deaths among
them occurring after IAA surgery at the index procedure.
Previously repaired IAA was not a risk factor. Eighty-two
Konno-type procedures were performed, with 2.4% early
mortality (vs 1.5% for non-Konno; P ¼ .4). Other risk fac-
tors were initially identified on univariable analysis (VSD
defect or CoA procedure at the index procedure). However,
on bivariable analysis, it was concluded that age<1 year
was a confounder and strongest predictor.Long-Term Survival and Freedom From
Reintervention
The Kaplan-Meier estimates are listed in Table 6. A sig-
nificant difference was found in long-term mortality be-
tween the 2 groups, with patients with CS more at risk
(HR, 4.53; 95% confidence interval [CI], 1.27-16.11;
P ¼ .02, adjusted by age). The independent risk factors
for long-term mortality were age < 1 year (HR, 6.72;
95% CI, 2.37-18.98, P<.001), having an MVabnormality
(HR, 4.11; 95% CI, 1.21-13.92; P ¼ .02). Having MV dis-
ease plus CoA resulted in an even greater risk (HR, 6.73;
95% CI, 1.64-27.59; P ¼ .008), although CoA alone was
not a risk factor.
In terms of freedom from subaortic reintervention, a very
significant difference was found between the SS and CS
groups (Figure 1). Examining the data in aggregate, the in-
dependent risk factors for reintervention were younger age
at the index procedure (HR, 0.1/y, 95% CI, 1.03-1.17;
P ¼ .002), a concomitant MV procedure (HR, 2.68; 95%
CI, 1.17-6.09; P ¼ .019), VSDþCoA (HR, 2.41; 95% CI,
1.12-5.14; P ¼ .023), and VSDþIAA (HR, 3.19; 95% CI,
1.26-8.04; P ¼ .014). Of the 9 patients with VSDþIAA
who required a SAS reintervention, 6 underwent repair
for residual CoA at the index procedure compared withgery c December 2014
TABLE 3. Patient- and procedure-related data
Variable Total* Simple SAS Complex SAS P value
Patients 1047 (100) 505 (48.2) 484 (46.2)
Age (y) 6.5 (2.7-12.2) 6.8 (3.5-12) 5.7 (2-12.4) .008
Sex
Male 644 (61.5) 311 (61.6) 300 (62.0) .87
Female 403 (38.5) 194 (38.4) 184 (38.0) .87
Age group
Neonate (<30 d) 19 (1.8) 2 (0.4) 17 (3.5) <.001
Infant (1-12 mo) 80 (7.6) 26 (5.1) 53 (11.0) <.001
Child (1-16 y) 804 (76.8) 421 (83.4) 338 (69.8) <.001
Young adult (16-40 y) 144 (13.8) 56 (11.1) 76 (15.7) .05
Follow-up (y)
Mean  SD 5.5  3.9 5.9  4.1 4.8  3.5 <.001
Median (IQR) 5.3 (2.2-8.9) 6.0 (2.5-9.7) 4.4 (1.9-7.5) <.001
Bypass time (min) 61 (45-88) 74 (51-112) 54 (40-70) <.001
Crossclamp time (min) 37 (26-55) 32 (24-45) 45 (32-75) <.001
Circulatory arrest 44 (4.5) 7 (1.4) 35 (7.2) <.001
Circulatory arrest time (min) 20 (9-30) 24 (3-36) 16 (9-29) .61
Hospital stay (d) 5 (4-7) 5 (4-6) 6 (5-9) <.001
Data presented as n (%), median (IQR), or mean SD. SAS, Subaortic stenosis; SD, standard deviation; IQR, interquartile range. *A total of 58 patients (5.6%) were not classifi-
able as simple or complex but were included in the total.
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tant AV procedure was found to be protective (HR, 0.29;
95% CI, 0.10-0.85; P ¼ .025). When late outcomes were
examined at different age intervals, all subgroups>1 year
old had comparable mortality results, better than those of
the 0- to 1-year cohort. In contrast, in the reintervention
group, a trend was found, with patients aged 0 to 10 years
most at risk (Figure 2). Competing risks analysis showed
that at 12 years, 85.8% of the patients were alive with no
reoperation, 3% had died without a reoperation, and
11.2% had undergone a reoperation. Also, the differences
in reintervention risk in the presence of death as a
competing event between the SS and CS forms were greater
for younger patients and less so for older ones (Figure 1, B).
In young adult patients, the results were excellent, and no
differences could be demonstrated.
Other Subgroup Analyses
AV disease. We considered the outcomes separately for the
subgroup of patients with documented AV pathologic fea-
tures at index (n ¼ 296), with a mean age of 10.3 years.
Of these, 121 (40.9%) had stenosis, 94 (31.8%) had regur-
gitation, 12 (4%) had mixed disease, and 69 (23.3%) had a
nonclassified abnormality. The AV procedure at the index
operation was none in 114 (38.5%), surgical valvuloplasty
in 59 (20%), AV replacement (AVR) in 108 (36.5%), and
an unclassified procedure in 15 (5%). The AVR type was
a Ross (or Ross-Konno) operation in 63, a mechanical pros-
thesis AVR (including root replacement or Bentall) in 21, an
unknown AVR type in 21, and bioprosthesis and homograft
in 1 each. Long-term mortality and reintervention-
smoothed hazard plots for these patients are shown inThe Journal of Thoracic and CarFigure 3. Younger age was a risk factor for AV/SAS reinter-
vention (HR, 0.12/y, 95% CI, 0.83-0.94; P<.001) but un-
dergoing an AVR procedure at index was protective
(naturally for aortic reintervention, but also for SAS reinter-
vention, P<.001; no such event was observed in the AVR
group, regardless of AVR type). The reoperations per-
formed in this subgroup are summarized in Table 7.
Konno procedure. Finally, we analyzed the subgroup of
82 patients who had undergone a Konno-type procedure,
studying the clinical and outcomes data (Table 8). Two early
deaths occurred, with 6 deaths during the total follow-up
period (median, 3.3 years), all in the Ross-Konno group.
In terms of reintervention, 3 early events occurred (a
Ross-Konno and an AVR after modified Konno and AV val-
vuloplasty after Ross-Konno that also resulted in the pa-
tient’s death at 18 days old) and 2 late events occurred (a
redo modified Konno and an AV valvuloplasty), resulting
in the estimates listed in Table 9.
DISCUSSION
We found that SAS relief can be performed with very
good results; however, the mortality and morbidity were
greatest in young patients with multiple abnormalities.
This is, to our knowledge, the largest observational multi-
center study reporting the surgical outcomes for SAS in
children and young adults. Furthermore, consecutive pa-
tients who had undergone surgery for this condition in the
United Kingdom for>1 decade were analyzed. Although
the clinical detail was scant, the assumption was that the
local multidisciplinary groups considered all patient factors
and surgical preference in recommending a certain proce-
dure and its timing. The echocardiographic details werediovascular Surgery c Volume 148, Number 6 2621
TABLE 4. Neonatal subaortic stenosis relief group—clinical data, procedures, and outcomes summary
Patient age (d);
weight (kg) Additional diagnoses Index procedure Other procedures (age; y) Life status
1; 2.8 Aorto-LV tunnel SAS relief, PDA closure, ECMO
needed
None Died in hospital (day 39
postoperatively)
4; 4 CoA, ASD, VSD SAS relief, CoA repair, ASD and
VSD closure
NA Alive at 3.6 y
4; 2.5 VSD, AV disease SAS relief, Bentall operation, VSD
closure
NA Alive at discharge (9 d);
lost to follow-up
5; 3.5 IAA, VSD SAS relief, IAA repair, VSD closure None Died in hospital (day 27
postoperatively)
6; 3 IAA, VSD SAS relief þ IAA repair, VSD closure SAS relief (1 y) Died at 5.5 y
6; 2.9 CoA, VSD, AV stenosis CoA repair, VSD closure BAV (4 mo)
RossþSAS relief (8 mo)
Died in hospital (day 4
after Ross)
7; 4 AV stenosis, ALCAPA Ross-Konno operation, ALCAPA
repair
Unknown procedure (5.4 y)
RVOT procedure (5.6 y)
Alive at 8.7 y
8; 3.5 AV stenosis SAS relief, SAV NA Alive at 5.3 y
8; 3.1 IAA, VSD SAS relief, IAA repair, VSD closure Subaortic shelf resection
(2.5 y)
Alive at 3.7 y
9; 4.2 AV stenosis, ASD SAS relief, aortic root replacement
(non-Ross), ASD closure
BAV (3 d)
Ross procedure (3 mo)
Alive at 1.3 y
9; 3.6 MV stenosis, AV stenosis, CoA,
VSD, ASD
SAS relief, SAV, CoA repair Balloon dilatation of re-CoA
(10 mo)
ASD closure (2.8 y)
Alive at 6.9 y
9; 3.4 AV stenosis Ross-Konno operation SAV (17 d) Died in hospital (day 20
after SAV)
10; 3.6 CoA, VSD SAS relief, CoA repair, VSD closure NA Alive at 1 y
11; 3 VSD SAS relief, VSD closure NA Alive at discharge (27 d);
lost to follow-up
11; 3.5 AV stenosis, CoA, ASD, PDA SAS relief, CoA repair, ASD and PDA
closure
SAV (1.5 y)
Ross-Konno (4.5 y)
Alive at 6 y
11; 3.8 CoA SAS relief, CoA repair None Died in hospital (day 34
postoperatively)
12; 8.4 DiGeorge syndrome, AV stenosis SAS relief, SAV BAV (9 y) Alive at 11.3 y
21; 3.3 MV regurgitation, AV stenosis Ross-Konno operation Previous SAV (2 d)
MVR (24 d)
RVOTO procedure (1.2 y)
Unknown procedure (2.2 y)
Died 99 d after unknown
procedure
21; 4 AV stenosis, VSD Ross-Konno operation NA Alive at 10.2 y
LV, Left ventricular; SAS, subaortic stenosis; PDA, patent arterial duct; ECMO, extracorporeal membrane oxygenation; CoA, coarctation of the aorta; ASD, atrial septal defect;
VSD, ventricular septal defect;NA, not available; AV, aortic valve; IAA, interrupted aortic arch; BAV, balloon aortic valvulotomy; ALCAPA, anomalous left coronary artery from the
pulmonary artery; RVOT, right ventricular outflow tract; SAV, surgical aortic valvulotomy; MV, mitral valve; MVR, mitral valve replacement; RVOTO, RVOT obstruction.
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outcomes data. We lacked data on the incidence and preva-
lence of LV outflow tract obstruction at birth, because the
CCAD is a procedure-based audit; however, it could be
reasonably assumed that many of the estimates from the
Liverpool study performed from 1960 to 1991 were still
valid for the United Kingdom.9
Early Mortality
The overall mortality of 1.6% compares favorably with
some of the best single-center series, taking into account
that our UK cohort also included neonates and other consec-
utive patients undergoing complex surgery.2,4,10 It is
unsurprising to find age< 1 year, IAA, and MV surgery2622 The Journal of Thoracic and Cardiovascular Suras risk factors for hospital death. The association between
IAA and SAS can be very vexing and has been, itself,
subject to numerous clinical analyses. After reporting an
original series with 20% mortality, Jacobs and
colleagues11 highlighted a number of technical pitfalls
and even recommended a modification of the Norwood
principle in selected cases. Regarding the use of Ross-
Konno adding to the early mortality, this is also in line
with existing data. In a series comparing Ross and Ross-
Konno in children, Ruzmetov and colleagues12 encountered
only 3 early deaths in 78 patients (3.8%), but all occurred in
the Ross-Konno group. It was reassuring to see that in our
population, previous IAA repair was not a risk factor for
early death outside the index SAS procedure. However, 6gery c December 2014
TABLE 5. Complex SAS group clinical data at index
Variable Value
Total 484 (100)
Genetic disorder 22 (4.6)
Associated abnormalities
AV* 296 (61.2)
MVy 105 (21.7)
VSD 147 (30.4)
CoA or hypoplasia of the aorta 160 (33.1)
IAA 40 (8.3)
Tricuspid/pulmonary 31 (6.4)
Associated abnormalities (left heart)
One 253 (52.3)
Two 195 (40.3)
Three 31 (6.4)
Four 3 (0.6)
Concomitant procedures
AV repair 62 (12.8)
AVR 108 (22.3)
MV procedure 62 (12.8)
VSD correction 70 (14.5)
CoA or hypoplasia repair 30 (6.2)
IAA repair 4 (0.8)
Tricuspid, RVOT, pulmonary 24 (5.0)
Konno-type operationz 59 (12.2)
Data presented as n (%). AV, Aortic valve; MV, mitral valve; VSD, ventricular septal
defect; CoA, coarctation of the aorta; IAA, interrupted aortic arch; AVR, AV replace-
ment; RVOT, right ventricular outflow tract. *Three patients (7.9%) had an AVabnor-
mality noted only after the index operation. yTen patients (2.1%) had an MV
abnormality noted only after the index operation. zIncluded the Ross-Konno, modi-
fied Konno, and Konno-Rastan operations.
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Dof 11 early deaths (55%) occurred in patients<1 year old,
and age appears to be an important confounding factor. We
did not have enough events to determine the contribution of
other risk factors such as concomitant CoA repair or the
presence of a VSD (corrected or not).Long-Term Survival and Freedom From
Reintervention
The subdivision into SS and CS really becomes useful
when examining the long-term outcomes. Other investiga-
tors who divided their pediatric patients into SS and CS
groups evidently found worse outcomes for the complexTABLE 6. Survival and freedom from reintervention data for subaortic st
Variable Overall
Patients (procedures) 1047 (1142)
Survival (%)
30-d 98.40
5-y estimate* 98.00 (96.80-98.75)
12-y estimate* 97.12 (95.33-98.23)
Freedom from subaortic reintervention (%)
5-y estimate 92.33 (90.16-94.04)
12-y estimate 88.50 (85.50-90.90)
Data in parentheses are 95% confidence intervals, unless otherwise noted. SAS, Subaortic
The Journal of Thoracic and Carforms. Valeske and colleagues13 reported surgical recur-
rence of 46% for CS versus 16% for SS. Hirata and col-
leagues2 showed that the 15-year freedom from
reintervention was 90.4% versus 72.1% for the simple
and complex forms, respectively. These series are not
entirely comparable because the patient demographics
and definitions of SS and CS varied between publications.
Defining ‘‘complex’’ SAS is an arbitrary exercise. In our
CS group, we chose to include lesions on the valves above
and below and obstructive arch pathologic features (with or
without a VSD). We believed that the presence of a simple
VSDwould be a minor risk factor in the long term, although
some series will report ‘‘simple’’ pathology only as discrete
stenosis on a largely intact septum. In our SS group 19.2%
of patients underwent VSD repair, comparable to the 14.7%
reported by van der Linde and colleagues14 in their adult se-
ries. Overall, 26.4%were documented with a VSD, close to
the 32% reported by Kitchiner and colleagues.15 Any such
arbitrary classification will be further complicated by the
progressive and intertwined nature of these lesions; the
reason we chose our subgroups as we did. Coexisting MV
disease and CoA suggests these patients belong to the
Shone spectrum. Coexisting VSD and arch abnormalities
point to the possibility of a deviated septum.15-17 AV
disease is known to evolve in tandem with SAS, even
after a successful first operation. The recurrence of SAS
and the progression of AV disease have been linked to
several factors: timing or gradient at the first repair,1 the
proximity of SAS to AV,4 and persistently abnormal geom-
etry of the LVoutflow tract.18 Age at the first operation was
intimately associated with the long-term outcome in some
series,10 although others have postulated that young age at
the first operation is a surrogate for more severe Shone-
type lesions, which inevitably have more aggressive pro-
gression, even after initial treatment.4 When we split our
group into 4 age groups (neonates and infants, young chil-
dren, older children, and adults), it was also evident that
those<1 year old had generally worse outcomes but that
the other age groups had more or less similar outcomes dur-
ing the follow-up period. When we further compared the
simple and complex forms at different ages, it become
apparent that the complex form adds significantly to theenosis repair
Simple SAS Complex SAS
505 (531) 484 (530)
99.32 97.74
99.51 (98.07-99.88) 96.65 (94.28-98.05)
98.80 (95.62-99.67) 96.12 (93.42-97.73)
97.80 (95.61-98.90) 88.80 (84.76-91.83)
95.80 (92.35-97.70) 83.66 (78.45-87.71)
stenosis. *Survival estimate was for 30-days survivors.
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FIGURE1. A,Kaplan-Meier freedom from subaortic reintervention func-
tion comparing simple and complex subaortic stenosis (SAS). B, Compar-
ison of subaortic reoperation risk in simple versus complex SAS showing
estimated cumulative incidence function at 1 year of age and mean age
(8.7 years), respectively. Competing risks survival regression, adjusted
by age, was used, with death as the competing risk. HR, Hazard ratio.
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Survival by age group in SAS patients
FIGURE 2. Survivor function plots comparing age groups in terms of
long-term risks (Cox regression model adjusted by age group). The vertical
axis does not start at 0. A, Estimated long-term survival with hazard ratios
(HRs) stratified by age group. B, Estimated long-term freedom from sub-
aortic reintervention with HRs stratified by age group. SAS, Subaortic
stenosis.
FIGURE 3. Smoothed hazard function plots comparing the risk for
different outcomes on the subgroup that presented at the index operation
with subaortic stenosis (SAS) and aortic valve (AoV) pathology. Separate
plots were drawn for different failure events: death, AoV reintervention,
and SAS reintervention.
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Dreintervention risk at young ages and that this age group is at
greater risk of requiring a reoperation even with an isolated
lesion (Figures 1, B, and 2).
Our results have shown that the actuarial curves for SS
and CS do not particularly separate for survival at 12 years
(98.8% vs 96.1%); however, a significant difference was
found in the freedom from reintervention (95.8% vs
83.7%; Table 6). The aggregate data suggest that young
age at the first operation, Shone-type disease, and coexist-
ing arch abnormalities predispose to early recurrence and
mortality. This is in line with the available data; the reports
on Shone syndrome have typically been small, single-center
series. Although the patients fit the anatomic diagnosis, the
intervention can be quite limited. Brown and colleagues19
reported that some patients only require as little interven-
tion as CoA repair. In a similar series, St Louis and col-
leagues20 and Delmo Walter and colleagues21 noted that
treatment of Shone syndrome must be individualized to
allow growth of the left ventricular inflow and outflow
tracts. We found that the presence of a VSD with either2624 The Journal of Thoracic and Cardiovascular Surgery c December 2014
TABLE 7. AV reinterventions in the subgroup with associated AV pathology
First AV reintervention
Index AV procedure
None (n ¼ 114) AV repair (n ¼ 59) AVR (n ¼ 108) Unknown (n ¼ 15) Total (n ¼ 296)
None* 94 (82.4) 52 (88.1) 104 (96.3) 14 (93.3) 264 (89.2)
AVR 9 (7.9) 5 (8.5) 2 (1.85) 0 (0) 16 (5.4)
Balloon AV valvulotomy 7 (6.2) 1 (1.7) 0 (0) 0 (0) 8 (2.7)
Surgical AV valvulotomyy 4 (3.5) 1 (1.7) 2 (1.85) 1 (6.7) 8 (2.7)
All AV reintervention types 20 (17.6) 7 (11.9) 4 (3.7) 1 (6.7) 32 (10.8)
Data presented as n (%). Later reinterventions: 5 of 32 patients (16.6%) underwent a second AV reintervention (2 AVRs, 1 root replacement with valvular resuspension, and 1
redo BAV); 2 of 32 patients (6.25%) underwent SAS relief reintervention after BAV (1modified Konno and 1 simple obstruction relief); 1 of 32 patients (3.1%) underwent a third
reoperation (Konno-Rastan after BAVand non-Ross root replacement during the 12-year follow-up period). AV, Aortic valve; AVR, AV replacement. *Three patients underwent
only SAS relief as their second operation. yOf the 8 patients with surgical AV repair, 4 also underwent concomitant SAS relief.
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DCoA or an IAA led to greater risk of SAS reintervention,
and we could speculate this results from septal malalign-
ment, which was previously linked to younger age at SAS
relief but not greater rates of recurrence.15 Another inter-
esting finding was that 6 of 9 patients who required SAS re-
intervention from the VSDþIAA group had previously
undergone an arch reintervention (consistent with a previ-
ous Congenital Heart Surgeons Society study).22 In the
VSDþCoA group, only 2 of 12 patients had previously un-
dergone an arch reintervention. This might point to complex
relationships among left-sided obstructions, their correc-
tion, and relapse.
It is intriguing to note that AVR at the index procedure
was protective in our series for the recurrence of SAS. It
could be argued that once a valve procedure has been per-
formed, it becomes more difficult to operate by way of
the aorta if restenosis occurs, and some patients could be
undertreated, or that the AVR improves the exposure of
the subaortic area and permits better clearance. However,
the data about patients who do not undergo an AV procedure
at index are convincing. When the valve and subaortic
membrane are close together, recurrence is more likely
and valve stenosis a common occurrence during follow-upTABLE 8. Clinical and demographic data for Konno-type procedures
Variable Modified Konno Ro
Patients (n) 14
Age (y)
Mean  SD 12.6  11.8 7
Median (IQR) 10.5 (2.1-16) 4.5
Sex
Male 10 (71.4) 45
Female 4 (28.6) 18
Age group
Neonate (<30 d) 0 4
Infant (1-12 mo) 1 (7.1) 16
Child (1-16 y) 9 (64.3) 37
Young adult (16-40 y) 4 (28.6) 6
Previous procedures
AV 2 (14.3) 31
SAS repair 5 (35.7) 13
Data presented as mean  SD, median (IQR), or n (%). SD, Standard deviation; IQR, int
The Journal of Thoracic and Carafter SAS resection.4,23 Our results, however, suggest that
in practice, these 2 individual lesions can be treated on
their own merit and, when AVR is required, this does not
negatively affect SAS freedom from reintervention.
However, a prospective design would be best suited to
study the interactions between AV and SAS pathologic
features and determine the best indications for treatment.
Overall, it appears that patients have a greater risk of
death and AV reintervention early during the follow-up
period and a greater risk of SAS reintervention later
(Figure 3).
For the Konno-type procedures, we found good long-
term results, with 92% survival at 10 years, comparable
to those previously reported.12,24,25 However, important
variations were present among the studies. As expected,
pulmonary and AV reinterventions were needed in the
Ross-Konno patients and SAS relapse after modified Konno
required reoperation.
Study Limitations
The present study was a retrospective study with limited
clinical data; however, we had complete procedural
coverage of consecutive national patients. The prevalencess-Konno Konno-Rastan Overall
63 5 82
.7  8.5 18.1  12.0 9.2  9.6
(0.6-12.2) 16.6 (8.3-29.4) 7.6 (0.9-13.1)
(71.4) 3 (60) 58 (70.7)
(28.6) 2 (40) 24 (29.3)
(6.4) 0 4 (4.8)
(25.4) 0 17 (20.7)
(58.7) 2 (40) 48 (58.6)
(9.5) 3 (60) 13 (15.9)
(49.2) 2 (40) 35 (42.7)
(20.6) 1 (20) 19 (23.2)
erquartile range; SAS, subaortic stenosis; AV, aortic valve.
diovascular Surgery c Volume 148, Number 6 2625
TABLE 9. Survival and freedom from reintervention for Konno-type
procedures
Survival %
30-d survival 97.6
10-y survival 92.50 (82.72-96.82)
10-y freedom from reintervention
Subaortic 96.55 (86.47-99.16)
Aortic 92.61 (79.35-97.49)
Pulmonary* 68.71 (49.59-81.81)
Data in parentheses are 95% confidence intervals. *Calculated for 63 Ross-Konno
patients.
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Dof associated abnormalities in this group was comparable to
those previously reported in other studies,9,26 suggesting
that the CCAD guidelines for reporting27 are able to
generate reliable data. However, information about the
sequence of events from the initial diagnosis was limited.
This did not allow consideration of the effects of the timing
of repairing the associated defects on SAS progression. It
also made it difficult to separate the presence of another ab-
normality from the attempt to correct it at some point as a
risk factor (ie, the presence of an associated anomaly corre-
lated with the need for repair). The CCAD reporting of
valve lesions and their severity is more discretionary than
the need for accurate procedural data. Our report, therefore,
was limited in its ability to determine the contribution of
associated lesions to SAS progression when these lesions
were below the surgical radar. All these issues might ulti-
mately have led to some misclassification for the simple/
complex dichotomization. Also being a procedure-based
rather than patient-based audit, a true (diagnosis-centered)
prognosis of SAS could not be determined. Finally, we
could not analyze the role of myectomy. Also, some patients
had incomplete follow-up data (because of geographical
reasons; thus, we assumed they did not introduce bias).
CONCLUSIONS
The present complete coverage national audit of consec-
utive patients has shown that the contemporary results of
SAS surgery are good for both simple and complex sub-
types. However, the complex form carries the larger part
of the mortality and morbidity burden.
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